Recommended dilutions: Western blot analysis: 1-2 µg/ml, Immunohistochemical analysis: 5 µg/ml. However, this need to be optimized based on the research applications.
Figure-1: Western blot analysis of SLC31A1. Anti-SLC31A1 antibody (Clone: ABM5D89) was tested at 1 µg/ml on (1) T98G and (2) THP1 lysates.
Figure-2: Immunohistochemical analysis of SLC31A1 in Adenocarcinoma cell of human Stomach using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
Figure-3: Immunohistochemical analysis of SLC31A1 in human Colon tissue using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
Figure-4: Immunohistochemical analysis of SLC31A1 in human Kidney tissue using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
Figure-5: Immunohistochemical analysis of SLC31A1 in human Placenta tissue using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
Figure-6: Immunohistochemical analysis of SLC31A1 in human Prostate tissue using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
Figure-7: Immunohistochemical analysis of SLC31A1 in human Skin tissue using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
Figure-8: Immunohistochemical analysis of SLC31A1 in human Stomach tissue using Anti-SLC31A1 antibody (Clone: ABM5D89) at 5 µg/ml.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten